Search Results - "Lankester, A W"

Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia by KNECHTLI, C. J. C, GOULDEN, N. J, CLARKE, E, LANKESTER, A. W, CORNISH, J. M, PAMPHILON, D. H, STEWARD, C. G, OAKHILL, A, HANCOCK, J. P, GRANDAGE, V. L. G, HARRIS, E. L, GARLAND, R. J, JONES, C. G, ROWBOTTOM, A. W, HUNT, L. P, GREEN, A. F

“…The efficacy of allografting in acute lymphoblastic leukemia (ALL) is heavily influenced by remission status at the time of transplant. Using polymerase chain…”
Get full text

Real-time quantitative PCR for detection of minimal residual disease before allogeneic stem cell transplantation predicts outcome in children with acute lymphoblastic leukemia by van der Velden, V H, Joosten, S A, Willemse, M J, van Wering, E R, Lankester, A W, van Dongen, J J, Hoogerbrugge, P M

Get full text

Minimal residual disease status as a predictor of relapse after allogeneic bone marrow transplantation for children with acute lymphoblastic leukaemia by KNECHTLI, C. J. C, GOULDEN, N. J, LANKESTER, A. W, POTTER, M. N, CORNISH, J. M, PAMPHILON, D. H, STEWARD, C. G, OAKHILL, A, HANCOCK, J. P, HARRIS, E. L, GARLAND, R. J, JONES, C. G, GRANDAGE, V. L. G, ROWBOTTOM, A. W, GREEN, A. F, CLARKE, E

“…We have analysed the behaviour of minimal residual disease (MRD) after allogeneic bone marrow transplantation (allo-BMT) in 71 children with acute…”
Get full text